PPI Pharmaceuticals

Scientist-led leadership in PPI oncology discovery

PPI Pharmaceuticals is led by Campbell McInnes, Ph.D., President and Chief Scientific Officer. The advisory board includes collaborators in cancer pharmacology, functional genomics, and Polo-like kinase biology.

President and Chief Scientific Officer

Headshot of Campbell McInnes, Ph.D.

Education

  • Ph.D. in Organic Chemistry, University of Edinburgh, Scotland, UK (1991)

President and Chief Scientific Officer

Campbell McInnes, Ph.D.

Professor in Medicinal Chemistry, University of South Carolina

Experience

Campbell McInnes, Ph.D., is Professor of Medicinal Chemistry at the University of South Carolina, where he has served since 2006. He has 30 years of research experience and 25 years in cancer drug discovery.

  • Head of the Structure Based Design Group, Cyclacel Pharmaceuticals, Dundee, UK (1999–2006)
  • Professor in Medicinal Chemistry, University of South Carolina since 2006
Recent publications on PubMed

Consultants and Advisory Board

Headshot of Michael Wyatt, Ph.D.

Consultant and Advisory Board Member

Michael Wyatt, Ph.D.

Professor in Biomedicinal Chemistry, University of South Carolina

  • 30 years of research experience in cancer pharmacology
  • Ph.D. in Molecular Pharmacology, University College London (1996)
  • Postdoctoral training in Genetic Toxicology, Harvard School of Public Health
  • Joined the University of South Carolina in 1999
Headshot of Ozgur Sahin, Ph.D.

Consultant and Advisory Board Member

Ozgur Sahin, Ph.D.

Professor and Endowed Chair, Department of Biochemistry & Molecular Biology, Medical University of South Carolina

  • 20 years of cancer biology research in functional genomics, bioinformatics, and drug discovery
  • Ph.D. in Molecular Pharmacology, University of Heidelberg and the German Cancer Research Center (2008)
  • Founder and President, LoxiGen, Inc., Charleston, South Carolina
Headshot of Mourad Sanhaji, Ph.D.

Consultant and Advisory Board Member

Mourad Sanhaji, Ph.D.

Group Leader, Molecular Oncology, Goethe University Frankfurt

  • Expert in Polo-like kinase cancer biology
  • Ph.D. in Cellular and Molecular Biology, Goethe University (2013), with K. Strebhardt
McInnes Research Group at USC
Campbell McInnes with the McInnes Research Group at the University of South Carolina